EL-12 is an active drug and metabolised by CYP2C19. 26% of the population are classified as CYP2C19 poor metabolisers.
In these patients, the standard dose of EL-12 is likely to result in:

Question

EL-12 is an active drug and metabolised by CYP2C19.  26% of the population are classified as CYP2C19 poor metabolisers. In these patients, the standard dose of EL-12 is likely to result in:

Accepted Answer

improvement in depression symptoms with increased risk of arrhythmia

Answer

worsening of depression symptoms with decreased risk of arrhythmia

Answer

Increased risk of side effects such as arrhythmia but reduced therapeutic outcomes

Answer

reduced effectiveness of the drug and with decreased risk of arrhythmia

Crowdly

EL-12 is an active drug and metabolised by CYP2C19. 26% of the population are ...

Want instant access to all verified answers on learning.monash.edu?